Company
Polpharma
Polpharma has 3 drugs tracked on RxWires: 1 post-market, 1 in Phase 3, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| placebo/valsartan | Post-Market | First Time Dual Chamber Pacemaker Implantation |
| Intravenous (IV) infusions | Phase 3 | Relapsing-Remitting Multiple Sclerosis (RRMS) |
| US-Ocrevus | Phase 1 | Multiple Sclerosis |
Latest
No recent events.
Follow Polpharma on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.